{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:48:09Z","timestamp":1790200089569,"version":"4.1.0"},"reference-count":74,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Unicentric Castleman disease (UCD) is a dynamic entity with a wide spectrum of morphologic findings. UCD can be further subdivided into hyaline-vascular and mixed\/plasmacytic variants. Hyaline-vascular UCD has both follicular and interfollicular (stromal) changes, and occasionally these lesions show a skewed representation of either the follicular or stromal compartments. Plasmacytosis is usually minimal in the hyaline-vascular variant. The mixed\/plasmacytic variant of UCD is composed of sheets of plasma cells often associated with a variable number of follicles with regressive changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To illustrate the differential diagnosis of UCD, as it is quite broad and includes lymphomas, plasma cell neoplasms, stromal neoplasms such as follicular dendritic cell sarcoma and vascular neoplasms, immunoglobulin G4\u2013related disease, infections, and other rare lesions. An additional objective is to enhance awareness of the morphologic features of UCD in excisional and in small core-needle biopsy specimens, the latter of which may inadvertently target follicle- or stroma-rich areas, causing diagnostic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>In this review, we provide readers a concise illustration of the morphologic spectrum of UCD that we have encountered in our practice and a brief discussion of entities in the differential diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>UCD exhibits a broad spectrum of morphologic changes, and awareness of these morphologic variations is key to avoid misdiagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0404-ra","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T08:32:41Z","timestamp":1678869161000},"page":"99-106","source":"Crossref","is-referenced-by-count":17,"title":["Unicentric Castleman Disease: Illustration of Its Morphologic Spectrum and Review of the Differential Diagnosis"],"prefix":"10.5858","volume":"148","author":[{"given":"Siba","family":"El Hussein","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Rochester Medical Center, Rochester, New York (El Hussein, Evans)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Evans","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Rochester Medical Center, Rochester, New York (El Hussein, Evans)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Wang, Medeiros)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Wang, Medeiros)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"the Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston (Fang, Wang, Medeiros)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"2024010215143638500_i1543-2165-148-1-99-b01","doi-asserted-by":"crossref","unstructured":"Alaggio\n              R,\n            \n            \n              Amador\n              C,\n            \n            \n              Anagnostopoulos\n              I,\n            \n            et al.\n          \n          The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms.\nLeukemia.\n2022;\n36(7):\n1720\u2013\n1748.\ndoi:10.1038\/s41375-022-01620-2","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2024010215143638500_i1543-2165-148-1-99-b02","doi-asserted-by":"crossref","unstructured":"Syrykh\n              C,\n            \n            \n              Chaouat\n              C,\n            \n            \n              Poullot\n              E,\n            \n            et al.\n          \n          Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey.\nBlood.\n2022;\n140(24):\n2573\u2013\n2583.\ndoi:10.1182\/blood.2022015520","DOI":"10.1182\/blood.2022015520"},{"key":"2024010215143638500_i1543-2165-148-1-99-b03","unstructured":"Frizzera\n              G.\n            \n          \n          Castleman's disease and related disorders.\nSemin Diagn Pathol.\n1988;\n5(4):\n346\u2013\n364."},{"key":"2024010215143638500_i1543-2165-148-1-99-b04","doi-asserted-by":"crossref","unstructured":"Nguyen\n              DT,\n            \n            \n              Diamond\n              LW,\n            \n            \n              Hansmann\n              ML,\n            \n            et al.\n          \n          Castleman's disease: differences in follicular dendritic network in the hyaline vascular and plasma cell variants.\nHistopathology.\n1994;\n24(5):\n437\u2013\n443.\ndoi:10.1111\/j.1365-2559.1994.tb00552.x","DOI":"10.1111\/j.1365-2559.1994.tb00552.x"},{"key":"2024010215143638500_i1543-2165-148-1-99-b05","doi-asserted-by":"crossref","unstructured":"Danon\n              AD,\n            \n            \n              Krishnan\n              J,\n            \n            \n              Frizzera\n              G.\n            \n          \n          Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.\nVirchows Arch A Pathol Anat Histopathol.\n1993;\n423(5):\n369\u2013\n382.\ndoi:10.1007\/BF01607150","DOI":"10.1007\/BF01607150"},{"key":"2024010215143638500_i1543-2165-148-1-99-b06","doi-asserted-by":"crossref","unstructured":"Keller\n              AR,\n            \n            \n              Hochholzer\n              L,\n            \n            \n              Castleman\n              B.\n            \n          \n          Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.\nCancer.\n1972;\n29(3):\n670\u2013\n683.\ndoi:10.1002\/1097-0142(197203)29:3&lt;670::aid-cncr2820290321&gt;3.0.co;2-#","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"2024010215143638500_i1543-2165-148-1-99-b07","doi-asserted-by":"crossref","unstructured":"Wang\n              W,\n            \n            \n              Medeiros\n              LJ.\n            \n          \n          Castleman disease.\nSurg Pathol Clin.\n2019;\n12(3):\n849\u2013\n863.\ndoi:10.1016\/j.path.2019.03.003","DOI":"10.1016\/j.path.2019.03.003"},{"key":"2024010215143638500_i1543-2165-148-1-99-b08","doi-asserted-by":"crossref","unstructured":"Kojima\n              M,\n            \n            \n              Shimizu\n              K,\n            \n            \n              Ikota\n              H,\n            \n            et al.\n          \n          \u201cFollicular variant\u201d of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.\nJ Clin Exp Hematop.\n2008;\n48(2):\n39\u2013\n45.\ndoi:10.3960\/jslrt.48.39","DOI":"10.3960\/jslrt.48.39"},{"key":"2024010215143638500_i1543-2165-148-1-99-b09","doi-asserted-by":"crossref","unstructured":"Pina-Oviedo\n              S,\n            \n            \n              Miranda\n              RN,\n            \n            \n              Lin\n              P,\n            \n            \n              Manning\n              JT,\n            \n            \n              Medeiros\n              LJ.\n            \n          \n          Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature.\nHum Pathol.\n2017;\n68:\n136\u2013\n146.\ndoi:10.1016\/j.humpath.2017.08.024","DOI":"10.1016\/j.humpath.2017.08.024"},{"key":"2024010215143638500_i1543-2165-148-1-99-b10","doi-asserted-by":"crossref","unstructured":"Koh\n              J,\n            \n            \n              Jeon\n              YK.\n            \n          \n          Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease.\nJ Pathol Transl Med.\n2020;\n54(3):\n253\u2013\n257.\ndoi:10.4132\/jptm.2019.12.17","DOI":"10.4132\/jptm.2019.12.17"},{"key":"2024010215143638500_i1543-2165-148-1-99-b11","doi-asserted-by":"crossref","unstructured":"Nozawa\n              Y,\n            \n            \n              Hirao\n              M,\n            \n            \n              Kamimura\n              K,\n            \n            \n              Hara\n              Y,\n            \n            \n              Abe\n              M.\n            \n          \n          Unusual case of follicular lymphoma with hyaline-vascular follicles.\nPathol Int.\n2002;\n52(12):\n794\u2013\n795.\ndoi:10.1046\/j.1440-1827.2002.01421.x","DOI":"10.1046\/j.1440-1827.2002.01421.x"},{"key":"2024010215143638500_i1543-2165-148-1-99-b12","doi-asserted-by":"crossref","unstructured":"Siddiqi\n              IN,\n            \n            \n              Brynes\n              RK,\n            \n            \n              Wang\n              E.\n            \n          \n          B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study.\nAm J Clin Pathol.\n2011;\n135(6):\n901\u2013\n914.\ndoi:10.1309\/AJCPF5AESY7OWIXF","DOI":"10.1309\/AJCPF5AESY7OWIXF"},{"key":"2024010215143638500_i1543-2165-148-1-99-b13","unstructured":"Warnke\n              RA,\n            \n            \n              Weiss\n              LM,\n            \n            \n              Chan\n              JK,\n            \n            \n              Cleary\n              ML,\n            \n            \n              Dorfman\n              RF.\n            \n          \n          Malignant lymphoma, follicular (small cleaved, mixed, and large cell; centroblastic-centrocytic and centroblastic).\nIn:\nTumors of the Lymph Nodes and Spleen.\nWashington, DC:\nArmed Forces Institute of Pathology;1994:\n63\u2013118. Atlas of Tumor Pathology; 3rd series, fascicle 14."},{"key":"2024010215143638500_i1543-2165-148-1-99-b14","doi-asserted-by":"crossref","unstructured":"Ohgami\n              RS,\n            \n            \n              Zhao\n              S,\n            \n            \n              Ohgami\n              JK,\n            \n            et al.\n          \n          TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.\nAm J Surg Pathol.\n2012;\n36(11):\n1619\u2013\n1628.\ndoi:10.1097\/PAS.0b013e318264e223","DOI":"10.1097\/PAS.0b013e318264e223"},{"key":"2024010215143638500_i1543-2165-148-1-99-b15","doi-asserted-by":"crossref","unstructured":"Hartert\n              M,\n            \n            \n              Strobel\n              P,\n            \n            \n              Dahm\n              M,\n            \n            \n              Nix\n              W,\n            \n            \n              Marx\n              A,\n            \n            \n              Vahl\n              CF.\n            \n          \n          A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis.\nAm J Surg Pathol.\n2010;\n34(5):\n742\u2013\n745.\ndoi:10.1097\/PAS.0b013e3181d7a2ee","DOI":"10.1097\/PAS.0b013e3181d7a2ee"},{"key":"2024010215143638500_i1543-2165-148-1-99-b16","doi-asserted-by":"crossref","unstructured":"Hsu\n              C,\n            \n            \n              Vega\n              F,\n            \n            \n              Grimes\n              LM,\n            \n            \n              Hunt\n              KK.\n            \n          \n          Follicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related?\n          \n            J Clin Oncol\n          .\n2011;\n29(13):\ne369\u2013\ne371.\ndoi:10.1200\/JCO.2010.32.7932","DOI":"10.1200\/JCO.2010.32.7932"},{"key":"2024010215143638500_i1543-2165-148-1-99-b17","doi-asserted-by":"crossref","unstructured":"Kim\n              WY,\n            \n            \n              Kim\n              H,\n            \n            \n              Jeon\n              YK,\n            \n            \n              Kim\n              CW.\n            \n          \n          Follicular dendritic cell sarcoma with immature T-cell proliferation.\nHum Pathol.\n2010;\n41(1):\n129\u2013\n133.\ndoi:10.1016\/j.humpath.2009.05.014","DOI":"10.1016\/j.humpath.2009.05.014"},{"key":"2024010215143638500_i1543-2165-148-1-99-b18","doi-asserted-by":"crossref","unstructured":"Kansal\n              R,\n            \n            \n              Nathwani\n              BN,\n            \n            \n              Yiakoumis\n              X,\n            \n            et al.\n          \n          Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.\nHum Pathol.\n2015;\n46(7):\n1057\u2013\n1061.\ndoi:10.1016\/j.humpath.2015.03.007","DOI":"10.1016\/j.humpath.2015.03.007"},{"key":"2024010215143638500_i1543-2165-148-1-99-b19","doi-asserted-by":"crossref","unstructured":"Ohgami\n              RS,\n            \n            \n              Arber\n              DA,\n            \n            \n              Zehnder\n              JL,\n            \n            \n              Natkunam\n              Y,\n            \n            \n              Warnke\n              RA.\n            \n          \n          Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.\nAdv Anat Pathol.\n2013;\n20(3):\n137\u2013\n140.\ndoi:10.1097\/PAP.0b013e31828d17ec","DOI":"10.1097\/PAP.0b013e31828d17ec"},{"key":"2024010215143638500_i1543-2165-148-1-99-b20","doi-asserted-by":"crossref","unstructured":"Cronin\n              DM,\n            \n            \n              Warnke\n              RA.\n            \n          \n          Castleman disease: an update on classification and the spectrum of associated lesions.\nAdv Anat Pathol.\n2009;\n16(4):\n236\u2013\n246.\ndoi:10.1097\/PAP.0b013e3181a9d4d3","DOI":"10.1097\/PAP.0b013e3181a9d4d3"},{"key":"2024010215143638500_i1543-2165-148-1-99-b21","doi-asserted-by":"crossref","unstructured":"Jones\n              SA.\n            \n          \n          Directing transition from innate to acquired immunity: defining a role for IL-6.\nJ Immunol.\n2005;\n175(6):\n3463\u2013\n3468.\ndoi:10.4049\/jimmunol.175.6.3463","DOI":"10.4049\/jimmunol.175.6.3463"},{"key":"2024010215143638500_i1543-2165-148-1-99-b22","doi-asserted-by":"crossref","unstructured":"Le\n              PT,\n            \n            \n              Lazorick\n              S,\n            \n            \n              Whichard\n              LP,\n            \n            et al.\n          \n          Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor.\nJ Immunol.\n1990;\n145(10):\n3310\u2013\n3315.","DOI":"10.4049\/jimmunol.145.10.3310"},{"key":"2024010215143638500_i1543-2165-148-1-99-b23","doi-asserted-by":"crossref","unstructured":"Facchetti\n              F,\n            \n            \n              Simbeni\n              M,\n            \n            \n              Lorenzi\n              L.\n            \n          \n          Follicular dendritic cell sarcoma.\nPathologica.\n2021;\n113(5):\n316\u2013\n329.\ndoi:10.32074\/1591-951X-331","DOI":"10.32074\/1591-951X-331"},{"key":"2024010215143638500_i1543-2165-148-1-99-b24","doi-asserted-by":"crossref","unstructured":"Lin\n              O,\n            \n            \n              Frizzera\n              G.\n            \n          \n          Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.\nAm J Surg Pathol.\n1997;\n21(11):\n1295\u2013\n1306.\ndoi:10.1097\/00000478-199711000-00004","DOI":"10.1097\/00000478-199711000-00004"},{"key":"2024010215143638500_i1543-2165-148-1-99-b25","doi-asserted-by":"crossref","unstructured":"Chan\n              JK,\n            \n            \n              Tsang\n              WY,\n            \n            \n              Ng\n              CS.\n            \n          \n          Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease.\nAm J Surg Pathol.\n1994;\n18(5):\n517\u2013\n525.\ndoi:10.1097\/00000478-199405000-00013","DOI":"10.1097\/00000478-199405000-00013"},{"key":"2024010215143638500_i1543-2165-148-1-99-b26","doi-asserted-by":"crossref","unstructured":"Chan\n              JK,\n            \n            \n              Fletcher\n              CD,\n            \n            \n              Nayler\n              SJ,\n            \n            \n              Cooper\n              K.\n            \n          \n          \n            Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer.;\n          \n          79\n          (2):\n294\u2013\n313.","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W"},{"key":"2024010215143638500_i1543-2165-148-1-99-b27","doi-asserted-by":"crossref","unstructured":"Marbaniang\n              E,\n            \n            \n              Khonglah\n              Y,\n            \n            \n              Dey\n              B,\n            \n            \n              Shunyu\n              B,\n            \n            \n              Gogoi\n              B.\n            \n          \n          Castleman's disease associated with calcifying fibrous tumor: a rare association with review of literature.\nJ Lab Physicians.\n2019;\n11(2):\n171\u2013\n173.\ndoi:10.4103\/JLP.JLP_16_19","DOI":"10.4103\/JLP.JLP_16_19"},{"key":"2024010215143638500_i1543-2165-148-1-99-b28","doi-asserted-by":"crossref","unstructured":"Dargent\n              JL,\n            \n            \n              Delplace\n              J,\n            \n            \n              Roufosse\n              C,\n            \n            \n              Laget\n              JP,\n            \n            \n              Lespagnard\n              L.\n            \n          \n          Development of a calcifying fibrous pseudotumour within a lesion of Castleman disease, hyaline-vascular subtype.\nJ Clin Pathol.\n1999;\n52(7):\n547\u2013\n549.\ndoi:10.1136\/jcp.52.7.547","DOI":"10.1136\/jcp.52.7.547"},{"key":"2024010215143638500_i1543-2165-148-1-99-b29","doi-asserted-by":"crossref","unstructured":"Azam\n              M,\n            \n            \n              Husen\n              YA,\n            \n            \n              Pervez\n              S.\n            \n          \n          Calcifying fibrous pseudotumor in association with hyaline vascular type Castleman's disease.\nIndian J Pathol Microbiol.\n2009;\n52(4):\n527\u2013\n529.\ndoi:10.4103\/0377-4929.56151","DOI":"10.4103\/0377-4929.56151"},{"key":"2024010215143638500_i1543-2165-148-1-99-b30","doi-asserted-by":"crossref","unstructured":"Valladolid\n              G,\n            \n            \n              Weisenberg\n              E,\n            \n            \n              Sundaresan\n              R,\n            \n            \n              Maker\n              AV.\n            \n          \n          Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy.\nJ Gastrointest Surg.\n2014;\n18(6):\n1205\u2013\n1208.\ndoi:10.1007\/s11605-014-2458-8","DOI":"10.1007\/s11605-014-2458-8"},{"key":"2024010215143638500_i1543-2165-148-1-99-b31","unstructured":"Ma\n              H,\n            \n            \n              Jiang\n              M,\n            \n            \n              Xiao\n              W.\n            \n          \n          A rare stroma-rich variant of hyaline-vascular Castleman's disease associated with calcifying fibrous pseudotumor.\nInt J Clin Exp Pathol.\n2015;\n8(3):\n3362\u2013\n3364."},{"key":"2024010215143638500_i1543-2165-148-1-99-b32","doi-asserted-by":"crossref","unstructured":"Harmankaya\n              I,\n            \n            \n              Ugras\n              NS,\n            \n            \n              Sekmenli\n              T,\n            \n            \n              Demir\n              F,\n            \n            \n              Koksal\n              Y.\n            \n          \n          Calcified fibrous pseudotumor with Castleman disease.\nAutops Case Rep.\n2018;\n8(3):\ne2018033.\ndoi:10.4322\/acr.2018.033","DOI":"10.4322\/acr.2018.033"},{"key":"2024010215143638500_i1543-2165-148-1-99-b33","doi-asserted-by":"crossref","unstructured":"Rollins-Raval\n              MA,\n            \n            \n              Marafioti\n              T,\n            \n            \n              Swerdlow\n              SH,\n            \n            \n              Roth\n              CG.\n            \n          \n          The number and growth pattern of plasmacytoid dendritic cells vary in different types of reactive lymph nodes: an immunohistochemical study.\nHum Pathol.\n2013;\n44(6):\n1003\u2013\n1010.\ndoi:10.1016\/j.humpath.2012.08.020","DOI":"10.1016\/j.humpath.2012.08.020"},{"key":"2024010215143638500_i1543-2165-148-1-99-b34","doi-asserted-by":"crossref","unstructured":"Harris\n              NL,\n            \n            \n              Bhan\n              AK.\n            \n          \n          \u201cPlasmacytoid T cells\u201d in Castleman's disease: immunohistologic phenotype.\nAm J Surg Pathol.\n1987;\n11(2):\n109\u2013\n113.\ndoi:10.1097\/00000478-198702000-00004","DOI":"10.1097\/00000478-198702000-00004"},{"key":"2024010215143638500_i1543-2165-148-1-99-b35","doi-asserted-by":"crossref","unstructured":"Chen\n              HC,\n            \n            \n              Wang\n              RC,\n            \n            \n              Tsai\n              HP,\n            \n            \n              Medeiros\n              LJ,\n            \n            \n              Chang\n              KC.\n            \n          \n          Morphologic spectrum of lymphadenopathy in drug reaction with eosinophilia and systemic symptoms syndrome.\nArch Pathol Lab Med.\n2022;\n146(9):\n1084\u2013\n1093.\ndoi:10.5858\/arpa.2021-0087-OA","DOI":"10.5858\/arpa.2021-0087-OA"},{"key":"2024010215143638500_i1543-2165-148-1-99-b36","doi-asserted-by":"crossref","unstructured":"Sozzani\n              S,\n            \n            \n              Del Prete\n              A,\n            \n            \n              Bosisio\n              D.\n            \n          \n          Dendritic cell recruitment and activation in autoimmunity.\nJ Autoimmun.\n2017;\n85:\n126\u2013\n140.\ndoi:10.1016\/j.jaut.2017.07.012","DOI":"10.1016\/j.jaut.2017.07.012"},{"key":"2024010215143638500_i1543-2165-148-1-99-b37","doi-asserted-by":"crossref","unstructured":"Ronnblom\n              L,\n            \n            \n              Alm\n              GV.\n            \n          \n          A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus.\nJ Exp Med.\n2001;\n194(12):\nF59\u2013\nF63.\ndoi:10.1084\/jem.194.12.f59","DOI":"10.1084\/jem.194.12.f59"},{"key":"2024010215143638500_i1543-2165-148-1-99-b38","doi-asserted-by":"crossref","unstructured":"Sukswai\n              N,\n            \n            \n              Jung\n              HR,\n            \n            \n              Amr\n              SS,\n            \n            et al.\n          \n          Immunopathology of Kikuchi-Fujimoto disease: a reappraisal using novel immunohistochemistry markers.\nHistopathology.\n2020;\n77(2):\n262\u2013\n274.\ndoi:10.1111\/his.14050","DOI":"10.1111\/his.14050"},{"key":"2024010215143638500_i1543-2165-148-1-99-b39","doi-asserted-by":"crossref","unstructured":"Vermi\n              W,\n            \n            \n              Facchetti\n              F,\n            \n            \n              Rosati\n              S,\n            \n            et al.\n          \n          Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders.\nAm J Surg Pathol.\n2004;\n28(5):\n585\u2013\n595.\ndoi:10.1097\/00000478-200405000-00004","DOI":"10.1097\/00000478-200405000-00004"},{"key":"2024010215143638500_i1543-2165-148-1-99-b40","doi-asserted-by":"crossref","unstructured":"Harris\n              NL,\n            \n            \n              Demirjian\n              Z.\n            \n          \n          Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia: histologic and immunohistologic characterization.\nAm J Surg Pathol.\n1991;\n15(1):\n87\u2013\n95.\ndoi:10.1097\/00000478-199101000-00011","DOI":"10.1097\/00000478-199101000-00011"},{"key":"2024010215143638500_i1543-2165-148-1-99-b41","doi-asserted-by":"crossref","unstructured":"Facchetti\n              F,\n            \n            \n              De Wolf-Peeters\n              C,\n            \n            \n              Kennes\n              C,\n            \n            et al.\n          \n          Leukemia-associated lymph node infiltrates of plasmacytoid monocytes (so-called plasmacytoid T-cells): evidence for two distinct histological and immunophenotypical patterns.\nAm J Surg Pathol.\n1990;\n14(2):\n101\u2013\n112.\ndoi:10.1097\/00000478-199002000-00001","DOI":"10.1097\/00000478-199002000-00001"},{"key":"2024010215143638500_i1543-2165-148-1-99-b42","doi-asserted-by":"crossref","unstructured":"Beiske\n              K,\n            \n            \n              Langholm\n              R,\n            \n            \n              Godal\n              T,\n            \n            \n              Marton\n              PF.\n            \n          \n          T-zone lymphoma with predominance of \u201cplasmacytoid T-cells\u201d associated with myelomonocytic leukaemia\u2014a distinct clinicopathological entity.\nJ Pathol.\n1986;\n150(4):\n247\u2013\n255.\ndoi:10.1002\/path.1711500404","DOI":"10.1002\/path.1711500404"},{"key":"2024010215143638500_i1543-2165-148-1-99-b43","doi-asserted-by":"crossref","unstructured":"Baddoura\n              FK,\n            \n            \n              Hanson\n              C,\n            \n            \n              Chan\n              WC.\n            \n          \n          Plasmacytoid monocyte proliferation associated with myeloproliferative disorders.\nCancer.\n1992;\n69(6):\n1457\u2013\n1467.\ndoi:10.1002\/1097-0142(19920315)69:6&lt;1457::aid-cncr2820690625&gt;3.0.co;2-f","DOI":"10.1002\/1097-0142(19920315)69:6<1457::AID-CNCR2820690625>3.0.CO;2-F"},{"key":"2024010215143638500_i1543-2165-148-1-99-b44","doi-asserted-by":"crossref","unstructured":"Khoury\n              JD,\n            \n            \n              Medeiros\n              LJ,\n            \n            \n              Manning\n              JT,\n            \n            \n              Sulak\n              LE,\n            \n            \n              Bueso-Ramos\n              C,\n            \n            \n              Jones\n              D.\n            \n          \n          CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.\nCancer.\n2002;\n94(9):\n2401\u2013\n2418.\ndoi:10.1002\/cncr.10489","DOI":"10.1002\/cncr.10489"},{"key":"2024010215143638500_i1543-2165-148-1-99-b45","doi-asserted-by":"crossref","unstructured":"Kojima\n              M,\n            \n            \n              Motoori\n              T,\n            \n            \n              Asano\n              S,\n            \n            \n              Nakamura\n              S.\n            \n          \n          Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.\nPathol Res Pract.\n2007;\n203(6):\n423\u2013\n431.\ndoi:10.1016\/j.prp.2007.03.002","DOI":"10.1016\/j.prp.2007.03.002"},{"key":"2024010215143638500_i1543-2165-148-1-99-b46","doi-asserted-by":"crossref","unstructured":"Kim\n              HA,\n            \n            \n              Kwon\n              JE,\n            \n            \n              Yim\n              H,\n            \n            \n              Suh\n              CH,\n            \n            \n              Jung\n              JY,\n            \n            \n              Han\n              JH.\n            \n          \n          The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset Still disease: a comprehensive analysis of 40 cases.\nMedicine (Baltimore).\n2015;\n94(17):\ne787.\ndoi:10.1097\/MD.0000000000000787","DOI":"10.1097\/MD.0000000000000787"},{"key":"2024010215143638500_i1543-2165-148-1-99-b47","doi-asserted-by":"crossref","unstructured":"Sfeir\n              MM,\n            \n            \n              Schuetz\n              A,\n            \n            \n              Van Besien\n              K,\n            \n            et al.\n          \n          Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes.\nJ Clin Pathol.\n2018;\n71(7):\n626\u2013\n630.\ndoi:10.1136\/jclinpath-2017-204777","DOI":"10.1136\/jclinpath-2017-204777"},{"key":"2024010215143638500_i1543-2165-148-1-99-b48","doi-asserted-by":"crossref","unstructured":"Lyapichev\n              KA,\n            \n            \n              You\n              MJ,\n            \n            \n              Vega\n              F,\n            \n            \n              Solis\n              LM,\n            \n            \n              Medeiros\n              LJ.\n            \n          \n          Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.\nVirchows Arch.\n2020;\n477(3):\n437\u2013\n444.\ndoi:10.1007\/s00428-020-02788-7","DOI":"10.1007\/s00428-020-02788-7"},{"key":"2024010215143638500_i1543-2165-148-1-99-b49","unstructured":"Zarate-Osorno\n              A,\n            \n            \n              Medeiros\n              LJ,\n            \n            \n              Danon\n              AD,\n            \n            \n              Neiman\n              RS.\n            \n          \n          Hodgkin's disease with coexistent Castleman-like histologic features: a report of three cases.\nArch Pathol Lab Med.\n1994;\n118(3):\n270\u2013\n274."},{"key":"2024010215143638500_i1543-2165-148-1-99-b50","doi-asserted-by":"crossref","unstructured":"Maheswaran\n              PR,\n            \n            \n              Ramsay\n              AD,\n            \n            \n              Norton\n              AJ,\n            \n            \n              Roche\n              WR.\n            \n          \n          Hodgkin's disease presenting with the histological features of Castleman's disease.\nHistopathology.\n1991;\n18(3):\n249\u2013\n253.\ndoi:10.1111\/j.1365-2559.1991.tb00833.x","DOI":"10.1111\/j.1365-2559.1991.tb00833.x"},{"key":"2024010215143638500_i1543-2165-148-1-99-b51","doi-asserted-by":"crossref","unstructured":"Radaszkiewicz\n              T,\n            \n            \n              Hansmann\n              ML,\n            \n            \n              Lennert\n              K.\n            \n          \n          Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant.\nHistopathology.\n1989;\n14(1):\n11\u2013\n24.\ndoi:10.1111\/j.1365-2559.1989.tb02110.x","DOI":"10.1111\/j.1365-2559.1989.tb02110.x"},{"key":"2024010215143638500_i1543-2165-148-1-99-b52","unstructured":"Chilosi\n              M,\n            \n            \n              Menestrina\n              F,\n            \n            \n              Lestani\n              M,\n            \n            et al.\n          \n          Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells: an immunohistochemical study with monoclonal antibodies.\nHistol Histopathol.\n1987;\n2(1):\n49\u2013\n55."},{"key":"2024010215143638500_i1543-2165-148-1-99-b53","unstructured":"Farooq\n              U,\n            \n            \n              Choudhary\n              S,\n            \n            \n              McLeod\n              MP,\n            \n            \n              Torchia\n              D,\n            \n            \n              Rongioletti\n              F,\n            \n            \n              Romanelli\n              P.\n            \n          \n          Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome.\nJ Clin Aesthet Dermatol.\n2012;\n5(11):\n25\u2013\n27."},{"key":"2024010215143638500_i1543-2165-148-1-99-b54","doi-asserted-by":"crossref","unstructured":"Rongioletti\n              F,\n            \n            \n              Romanelli\n              P,\n            \n            \n              Rebora\n              A.\n            \n          \n          Cutaneous mucinous angiomatosis as a presenting sign of bone plasmacytoma: a new case of (A)ESOP syndrome.\nJ Am Acad Dermatol.\n2006;\n55(5):\n909\u2013\n910.\ndoi:10.1016\/j.jaad.2006.04.072","DOI":"10.1016\/j.jaad.2006.04.072"},{"key":"2024010215143638500_i1543-2165-148-1-99-b55","doi-asserted-by":"crossref","unstructured":"Cheuk\n              W,\n            \n            \n              Chan\n              JK.\n            \n          \n          Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity.\nSemin Diagn Pathol.\n2012;\n29(4):\n226\u2013\n234.\ndoi:10.1053\/j.semdp.2012.07.001","DOI":"10.1053\/j.semdp.2012.07.001"},{"key":"2024010215143638500_i1543-2165-148-1-99-b56","doi-asserted-by":"crossref","unstructured":"Chen\n              YR,\n            \n            \n              Chen\n              YJ,\n            \n            \n              Wang\n              MC,\n            \n            \n              Medeiros\n              LJ,\n            \n            \n              Chang\n              KC.\n            \n          \n          A newly recognized histologic pattern of IgG4-related lymphadenopathy: expanding the morphologic spectrum.\nAm J Surg Pathol.\n2018;\n42(7):\n977\u2013\n982.\ndoi:10.1097\/PAS.0000000000001076","DOI":"10.1097\/PAS.0000000000001076"},{"key":"2024010215143638500_i1543-2165-148-1-99-b57","doi-asserted-by":"crossref","unstructured":"Sato\n              Y,\n            \n            \n              Kojima\n              M,\n            \n            \n              Takata\n              K,\n            \n            et al.\n          \n          Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.\nMod Pathol.\n2009;\n22(4):\n589\u2013\n599.\ndoi:10.1038\/modpathol.2009.17","DOI":"10.1038\/modpathol.2009.17"},{"key":"2024010215143638500_i1543-2165-148-1-99-b58","doi-asserted-by":"crossref","unstructured":"Nishimura\n              MF,\n            \n            \n              Igawa\n              T,\n            \n            \n              Gion\n              Y,\n            \n            et al.\n          \n          Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease: a clinicopathological study in comparison with IgG4-related disease.\nJ Pers Med.\n2020;\n10(4):\n269.\ndoi:10.3390\/jpm10040269","DOI":"10.3390\/jpm10040269"},{"key":"2024010215143638500_i1543-2165-148-1-99-b59","doi-asserted-by":"crossref","unstructured":"Terasaki\n              Y,\n            \n            \n              Ikushima\n              S,\n            \n            \n              Matsui\n              S,\n            \n            et al.\n          \n          Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.\nHistopathology.\n2017;\n70(7):\n1114\u2013\n1124.\ndoi:10.1111\/his.13186","DOI":"10.1111\/his.13186"},{"key":"2024010215143638500_i1543-2165-148-1-99-b60","doi-asserted-by":"crossref","unstructured":"Han\n              Y,\n            \n            \n              Igawa\n              T,\n            \n            \n              Ogino\n              K,\n            \n            et al.\n          \n          Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.\nJ Clin Exp Hematop.\n2020;\n60(1):\n1\u2013\n6.\ndoi:10.3960\/jslrt.19037","DOI":"10.3960\/jslrt.19037"},{"key":"2024010215143638500_i1543-2165-148-1-99-b61","doi-asserted-by":"crossref","unstructured":"Manabe\n              A,\n            \n            \n              Igawa\n              T,\n            \n            \n              Takeuchi\n              M,\n            \n            \n              Gion\n              Y,\n            \n            \n              Yoshino\n              T,\n            \n            \n              Sato\n              Y.\n            \n          \n          Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease.\nMed Mol Morphol.\n2017;\n50(1):\n34\u2013\n41.\ndoi:10.1007\/s00795-016-0145-4","DOI":"10.1007\/s00795-016-0145-4"},{"key":"2024010215143638500_i1543-2165-148-1-99-b62","doi-asserted-by":"crossref","unstructured":"Martin-Nares\n              E,\n            \n            \n              Hernandez-Molina\n              G,\n            \n            \n              Baenas\n              DF,\n            \n            \n              Paira\n              S.\n            \n          \n          IgG4-related disease: mimickers and diagnostic pitfalls.\nJ Clin Rheumatol.\n2022;\n28(2):\ne596\u2013\ne604.\ndoi:10.1097\/RHU.0000000000001787","DOI":"10.1097\/RHU.0000000000001787"},{"key":"2024010215143638500_i1543-2165-148-1-99-b63","doi-asserted-by":"crossref","unstructured":"Sasaki\n              T,\n            \n            \n              Akiyama\n              M,\n            \n            \n              Kaneko\n              Y,\n            \n            \n              Takeuchi\n              T.\n            \n          \n          IgG4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.\nRheumatology (Oxford).\n2022;\n61(2):\n490\u2013\n501.\ndoi:10.1093\/rheumatology\/keab634","DOI":"10.1093\/rheumatology\/keab634"},{"key":"2024010215143638500_i1543-2165-148-1-99-b64","doi-asserted-by":"crossref","unstructured":"Chang\n              KC,\n            \n            \n              Wang\n              YC,\n            \n            \n              Hung\n              LY,\n            \n            et al.\n          \n          Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease.\nMod Pathol.\n2014;\n27(6):\n823\u2013\n831.\ndoi:10.1038\/modpathol.2013.202","DOI":"10.1038\/modpathol.2013.202"},{"key":"2024010215143638500_i1543-2165-148-1-99-b65","doi-asserted-by":"crossref","unstructured":"Butzmann\n              A,\n            \n            \n              Kumar\n              J,\n            \n            \n              Sridhar\n              K,\n            \n            \n              Gollapudi\n              S,\n            \n            \n              Ohgami\n              RS.\n            \n          \n          A review of genetic abnormalities in unicentric and multicentric Castleman disease.\nBiology (Basel).\n2021;\n10(4):\n251.\ndoi:10.3390\/biology10040251","DOI":"10.3390\/biology10040251"},{"key":"2024010215143638500_i1543-2165-148-1-99-b66","unstructured":"Nakamura\n              H,\n            \n            \n              Nakaseko\n              C,\n            \n            \n              Ishii\n              A,\n            \n            et al.\n          \n          Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6 [in Japanese].\nRinsho Ketsueki.\n1993;\n34(2):\n212\u2013\n7."},{"key":"2024010215143638500_i1543-2165-148-1-99-b67","doi-asserted-by":"crossref","unstructured":"Pauwels\n              P,\n            \n            \n              Dal Cin\n              P,\n            \n            \n              Vlasveld\n              LT,\n            \n            \n              Aleva\n              RM,\n            \n            \n              van Erp\n              WF,\n            \n            \n              Jones\n              D.\n            \n          \n          A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.\nAm J Surg Pathol.\n2000;\n24(6):\n882\u2013\n888.\ndoi:10.1097\/00000478-200006000-00016","DOI":"10.1097\/00000478-200006000-00016"},{"key":"2024010215143638500_i1543-2165-148-1-99-b68","doi-asserted-by":"crossref","unstructured":"Chen\n              WC,\n            \n            \n              Jones\n              D,\n            \n            \n              Ho\n              CL,\n            \n            et al.\n          \n          Cytogenetic anomalies in hyaline vascular Castleman disease: report of two cases with reappraisal of histogenesis.\nCancer Genet Cytogenet.\n2006;\n164(2):\n110\u2013\n117.\ndoi:10.1016\/j.cancergencyto.2005.06.009","DOI":"10.1016\/j.cancergencyto.2005.06.009"},{"key":"2024010215143638500_i1543-2165-148-1-99-b69","doi-asserted-by":"crossref","unstructured":"Reichard\n              KK,\n            \n            \n              Robinett\n              S,\n            \n            \n              Foucar\n              MK.\n            \n          \n          Clonal cytogenetic abnormalities in the plasma cell variant of Castleman disease.\nCancer Genet.\n2011;\n204(6):\n323\u2013\n327.\ndoi:10.1016\/j.cancergen.2011.04.003","DOI":"10.1016\/j.cancergen.2011.04.003"},{"key":"2024010215143638500_i1543-2165-148-1-99-b70","doi-asserted-by":"crossref","unstructured":"Kojima\n              M,\n            \n            \n              Shimizu\n              S.\n            \n          \n          Hyaline vascular Castleman's disease representing 18 trisomy.\nJ Clin Exp Hematop.\n2018;\n58(1):\n36\u2013\n38.\ndoi:10.3960\/jslrt.17034","DOI":"10.3960\/jslrt.17034"},{"key":"2024010215143638500_i1543-2165-148-1-99-b71","doi-asserted-by":"crossref","unstructured":"Nagy\n              A,\n            \n            \n              Bhaduri\n              A,\n            \n            \n              Shahmarvand\n              N,\n            \n            et al.\n          \n          Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.\nBlood Adv.\n2018;\n2(5):\n481\u2013\n491.\ndoi:10.1182\/bloodadvances.2017009654","DOI":"10.1182\/bloodadvances.2017009654"},{"key":"2024010215143638500_i1543-2165-148-1-99-b72","doi-asserted-by":"crossref","unstructured":"Li\n              Z,\n            \n            \n              Lan\n              X,\n            \n            \n              Li\n              C,\n            \n            et al.\n          \n          Recurrent PDGFRB mutations in unicentric Castleman disease.\nLeukemia.\n2019;\n33(4):\n1035\u2013\n1038.\ndoi:10.1038\/s41375-018-0323-6","DOI":"10.1038\/s41375-018-0323-6"},{"key":"2024010215143638500_i1543-2165-148-1-99-b73","doi-asserted-by":"crossref","unstructured":"Baker\n              TS,\n            \n            \n              Gambino\n              KJ,\n            \n            \n              Schriefer\n              L,\n            \n            et al.\n          \n          A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease.\nBlood Adv.\n2018;\n2(21):\n2959\u2013\n2963.\ndoi:10.1182\/bloodadvances.2018023911","DOI":"10.1182\/bloodadvances.2018023911"},{"key":"2024010215143638500_i1543-2165-148-1-99-b74","doi-asserted-by":"crossref","unstructured":"Legras\n              A,\n            \n            \n              Tallet\n              A,\n            \n            \n              Didelot\n              A,\n            \n            et al.\n          \n          Clinical and molecular characteristics of unicentric mediastinal Castleman disease.\nJ Thorac Dis.\n2018;\n10(4):\n2079\u2013\n2088.\ndoi:10.21037\/jtd.2018.03.159","DOI":"10.21037\/jtd.2018.03.159"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/1\/99\/3308599\/i1543-2165-148-1-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/1\/99\/3308599\/i1543-2165-148-1-99.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:06Z","timestamp":1764790806000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/148\/1\/article-p99.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,15]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0404-ra","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,15]]}}}